A Parray
SnoRNAs and miRNAs networks underlying COVID-19 disease severity
Parray, A; Mir, FA; Doudin, A; Iskandarani, A; Danjuma, IMM; Kuni, RAT; Abdelmajid, A; Abdelhafez, I; Arif, R; Mulhim, M; Abukhattab, M; Dar, SR; Moustafa, A-EA; Elkord, E; Al Khal, AL; Elzouki, A-N; Cyprian, F
Authors
FA Mir
A Doudin
A Iskandarani
IMM Danjuma
RAT Kuni
A Abdelmajid
I Abdelhafez
R Arif
M Mulhim
M Abukhattab
SR Dar
A-EA Moustafa
E Elkord
AL Al Khal
A-N Elzouki
F Cyprian
Contributors
GA Sautto
Editor
RA Diotti
Editor
RB Abreu
Editor
Abstract
There is a lack of predictive markers for early and rapid identification of disease progression in COVID-19 patients. Our study aims at identifying microRNAs (miRNAs)/small nucleolar RNAs (snoRNAs) as potential biomarkers of COVID-19 severity. Using differential expression analysis of microarray data (n = 29), we identified hsa-miR-1246, ACA40, hsa-miR-4532, hsa-miR-145-5p, and ACA18 as the top five differentially expressed transcripts in severe versus asymptomatic, and ACA40, hsa-miR-3609, ENSG00000212378 (SNORD78), hsa-miR-1231, hsa-miR-885-3p as the most significant five in severe versus mild cases. Moreover, we found that white blood cell (WBC) count, absolute neutrophil count (ANC), neutrophil (%), lymphocyte (%), red blood cell (RBC) count, hemoglobin, hematocrit, D-Dimer, and albumin are significantly correlated with the identified differentially expressed miRNAs and snoRNAs. We report a unique miRNA and snoRNA profile that is associated with a higher risk of severity in a cohort of SARS-CoV-2 infected patients. Altogether, we present a differential expression analysis of COVID-19-associated microRNA (miRNA)/small nucleolar RNA (snoRNA) signature, highlighting their importance in SARS-CoV-2 infection.
Citation
Parray, A., Mir, F., Doudin, A., Iskandarani, A., Danjuma, I., Kuni, R., …Cyprian, F. (2021). SnoRNAs and miRNAs networks underlying COVID-19 disease severity. Vaccines, 9(10), e1056. https://doi.org/10.3390/vaccines9101056
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 19, 2021 |
Publication Date | Sep 23, 2021 |
Deposit Date | Sep 27, 2021 |
Publicly Available Date | Sep 27, 2021 |
Journal | Vaccines |
Publisher | MDPI |
Volume | 9 |
Issue | 10 |
Pages | e1056 |
DOI | https://doi.org/10.3390/vaccines9101056 |
Publisher URL | https://doi.org/10.3390/vaccines9101056 |
Related Public URLs | http://www.mdpi.com/journal/vaccines |
Additional Information | Additional Information : ** From MDPI via Jisc Publications Router ** Licence for this article: https://creativecommons.org/licenses/by/4.0/ **Journal IDs: eissn 2076-393X **History: published 23-09-2021; accepted 19-09-2021 Funders : Qatar University Grant Number: QUST-1-CMED-2021-2 |
Files
vaccines-09-01056.pdf
(4 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Downloadable Citations
About USIR
Administrator e-mail: library-research@salford.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search